Hence, USP18, GPX1, and RGL1 as they relate to SLE, may be potential ac4C-modified targets to explore the pathogenesis of SLE, which provides promising perspectives for additional study of ac4C-related pathogenic mechanisms. This evidence concerns the gene RGL1 and systemic lupus erythematosus.